Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE

The objective was to evaluate the predictive performance of the Colorectal Cancer Risk Assessment Tool (CCRAT) and three polygenic risk scores (Hsu et al., 2015; Law et al., 2019, Archambault et al., 2020) to predict the occurrence of colorectal cancer at five years in a Quebec population-based coho...

Full description

Bibliographic Details
Main Authors: Rodolphe Jantzen, Yves Payette, Thibault de Malliard, Catherine Labbé, Nolwenn Noisel, Philippe Broët
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:Preventive Medicine Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211335521003697
_version_ 1818330319216967680
author Rodolphe Jantzen
Yves Payette
Thibault de Malliard
Catherine Labbé
Nolwenn Noisel
Philippe Broët
author_facet Rodolphe Jantzen
Yves Payette
Thibault de Malliard
Catherine Labbé
Nolwenn Noisel
Philippe Broët
author_sort Rodolphe Jantzen
collection DOAJ
description The objective was to evaluate the predictive performance of the Colorectal Cancer Risk Assessment Tool (CCRAT) and three polygenic risk scores (Hsu et al., 2015; Law et al., 2019, Archambault et al., 2020) to predict the occurrence of colorectal cancer at five years in a Quebec population-based cohort. By using the CARTaGENE cohort, we computed the absolute risk of colorectal cancer with the CCRAT model, the polygenic risk scores (PRS) and combined clinico-genetic models (CCRAT + PRS). We also tailored the CCRAT model by using the marginal age-specific colorectal incidence rates in Canada and the risk score distribution. We reported the calibration and the discrimination. Performances of the PRSs, combined and tailored CCRAT models were compared to the original CCRAT model. The expected-to-observed ratio of the original CCRAT model was 0.54 [0.43–0.68]. The c-index was 74.79 [68.3–80.5]. The tailored CCRAT model improved the expected-to-observed ratio (0.74 [0.59–0.94]) and c-index (76.39 [69.7–82.1]). All PRS improved the expected-to-observed ratios (around 0.83, confidence intervals including one). PRSs’ c-indexes were not significantly different from CCRAT models. Results from the combined models were close to those from the PRS models, Archambault combined model’s c-index being significantly higher than the original and tailored CCRAT models (78.67 [70.8–86.5]; p < 0.001 and p = 0.028, respectively). In this Quebec cohort, CCRAT model has a good discrimination with a poor calibration. While the tailored CCRAT provides some gain in calibration, clinico-genetic models improved both calibration and discrimination. However, better calibrations must be obtained before a practical use among the inhabitants of Quebec province.
first_indexed 2024-12-13T13:02:04Z
format Article
id doaj.art-8ea7f089e4e54033b2d47f2498415f30
institution Directory Open Access Journal
issn 2211-3355
language English
last_indexed 2024-12-13T13:02:04Z
publishDate 2022-02-01
publisher Elsevier
record_format Article
series Preventive Medicine Reports
spelling doaj.art-8ea7f089e4e54033b2d47f2498415f302022-12-21T23:44:59ZengElsevierPreventive Medicine Reports2211-33552022-02-0125101678Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENERodolphe Jantzen0Yves Payette1Thibault de Malliard2Catherine Labbé3Nolwenn Noisel4Philippe Broët5CARTaGENE, Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada; Université de Montréal, Montréal, Québec, Canada; Corresponding author at: 3175 Chemin de la Côte-Sainte-Catherine, Montréal, QC H3T 1C5, Canada.CARTaGENE, Research Center, CHU Sainte-Justine, Montreal, Quebec, CanadaCARTaGENE, Research Center, CHU Sainte-Justine, Montreal, Quebec, CanadaCARTaGENE, Research Center, CHU Sainte-Justine, Montreal, Quebec, CanadaCARTaGENE, Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada; Université de Montréal, Montréal, Québec, CanadaCARTaGENE, Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada; Université de Montréal, Montréal, Québec, Canada; University Paris-Saclay, CESP, INSERM, Villejuif, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Hôpital Paul Brousse, 12 Avenue Paul Vaillant Couturier, 94807 Villejuif, FranceThe objective was to evaluate the predictive performance of the Colorectal Cancer Risk Assessment Tool (CCRAT) and three polygenic risk scores (Hsu et al., 2015; Law et al., 2019, Archambault et al., 2020) to predict the occurrence of colorectal cancer at five years in a Quebec population-based cohort. By using the CARTaGENE cohort, we computed the absolute risk of colorectal cancer with the CCRAT model, the polygenic risk scores (PRS) and combined clinico-genetic models (CCRAT + PRS). We also tailored the CCRAT model by using the marginal age-specific colorectal incidence rates in Canada and the risk score distribution. We reported the calibration and the discrimination. Performances of the PRSs, combined and tailored CCRAT models were compared to the original CCRAT model. The expected-to-observed ratio of the original CCRAT model was 0.54 [0.43–0.68]. The c-index was 74.79 [68.3–80.5]. The tailored CCRAT model improved the expected-to-observed ratio (0.74 [0.59–0.94]) and c-index (76.39 [69.7–82.1]). All PRS improved the expected-to-observed ratios (around 0.83, confidence intervals including one). PRSs’ c-indexes were not significantly different from CCRAT models. Results from the combined models were close to those from the PRS models, Archambault combined model’s c-index being significantly higher than the original and tailored CCRAT models (78.67 [70.8–86.5]; p < 0.001 and p = 0.028, respectively). In this Quebec cohort, CCRAT model has a good discrimination with a poor calibration. While the tailored CCRAT provides some gain in calibration, clinico-genetic models improved both calibration and discrimination. However, better calibrations must be obtained before a practical use among the inhabitants of Quebec province.http://www.sciencedirect.com/science/article/pii/S2211335521003697Polygenic risk score (PRS)CCRATModel calibrationModel discriminationAccuracyColorectal cancer occurrence
spellingShingle Rodolphe Jantzen
Yves Payette
Thibault de Malliard
Catherine Labbé
Nolwenn Noisel
Philippe Broët
Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE
Preventive Medicine Reports
Polygenic risk score (PRS)
CCRAT
Model calibration
Model discrimination
Accuracy
Colorectal cancer occurrence
title Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE
title_full Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE
title_fullStr Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE
title_full_unstemmed Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE
title_short Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE
title_sort five year absolute risk estimates of colorectal cancer based on ccrat model and polygenic risk scores a validation study using the quebec population based cohort cartagene
topic Polygenic risk score (PRS)
CCRAT
Model calibration
Model discrimination
Accuracy
Colorectal cancer occurrence
url http://www.sciencedirect.com/science/article/pii/S2211335521003697
work_keys_str_mv AT rodolphejantzen fiveyearabsoluteriskestimatesofcolorectalcancerbasedonccratmodelandpolygenicriskscoresavalidationstudyusingthequebecpopulationbasedcohortcartagene
AT yvespayette fiveyearabsoluteriskestimatesofcolorectalcancerbasedonccratmodelandpolygenicriskscoresavalidationstudyusingthequebecpopulationbasedcohortcartagene
AT thibaultdemalliard fiveyearabsoluteriskestimatesofcolorectalcancerbasedonccratmodelandpolygenicriskscoresavalidationstudyusingthequebecpopulationbasedcohortcartagene
AT catherinelabbe fiveyearabsoluteriskestimatesofcolorectalcancerbasedonccratmodelandpolygenicriskscoresavalidationstudyusingthequebecpopulationbasedcohortcartagene
AT nolwennnoisel fiveyearabsoluteriskestimatesofcolorectalcancerbasedonccratmodelandpolygenicriskscoresavalidationstudyusingthequebecpopulationbasedcohortcartagene
AT philippebroet fiveyearabsoluteriskestimatesofcolorectalcancerbasedonccratmodelandpolygenicriskscoresavalidationstudyusingthequebecpopulationbasedcohortcartagene